Tocqueville Asset Management’s Abiomed Inc ABMD Stock Holding History

Tocqueville Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,265	Closed	-$1.03M	–	681
2020 Q2	$1.03M	Hold	4,265	–	–	0.02%	385
2020 Q1	$619K	Buy	+4,265	New	+$708K	0.02%	421
2019 Q4	–	Sell	-1,625	Closed	-$289K	–	785
2019 Q3	$289K	Hold	1,625	–	–	﹤0.01%	657
2019 Q2	$423K	Sell	1,625 -535	-25%	-$142K	0.01%	631
2019 Q1	$617K	Buy	2,160 +390	+22%	+$130K	0.01%	550
2018 Q4	$575K	Hold	1,770	–	–	0.01%	536
2018 Q3	$796K	Buy	1,770 +70	+4%	+$27.6K	0.01%	536
2018 Q2	$695K	Buy	+1,700	New	+$616K	0.01%	559
2016 Q4	–	Sell	-7,600	Closed	-$977K	–	863
2016 Q3	$977K	Hold	7,600	–	–	0.01%	510
2016 Q2	$831K	Buy	7,600 +300	+4%	+$29.8K	0.01%	526
2016 Q1	$692K	Buy	7,300 +4,800	+192%	+$405K	0.01%	560
2015 Q4	$226K	Sell	2,500 -1,000	-29%	-$84.9K	﹤0.01%	826
2015 Q3	$325K	Buy	+3,500	New	+$308K	﹤0.01%	790

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tocqueville Asset Management's ABMD Position: Q3 2020 in Review

Tocqueville Asset Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 4,265 shares — an estimated $1.03M sold.

Tocqueville Asset Management first reported a position in ABMD in Q3 2015 and held it in 13 quarters. The position peaked at $1.03M in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

Tocqueville Asset Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
Tocqueville Asset Management sold 4,265 Abiomed Inc shares in Q3 2020, an estimated $1.03M.
Tocqueville Asset Management first reported a position in Abiomed Inc in Q3 2015 and held it in 13 quarters.
Tocqueville Asset Management's Abiomed Inc position peaked at $1.03M in Q2 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.